Logo image of GCTK

GLUCOTRACK INC (GCTK) Stock Fundamental Analysis

NASDAQ:GCTK - Nasdaq - US45824Q7051 - Common Stock - Currency: USD

6.5591  +0.25 (+3.95%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GCTK. GCTK was compared to 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of GCTK is average, but there are quite some concerns on its profitability. GCTK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GCTK had negative earnings in the past year.
In the past year GCTK has reported a negative cash flow from operations.
In the past 5 years GCTK always reported negative net income.
GCTK had a negative operating cash flow in each of the past 5 years.
GCTK Yearly Net Income VS EBIT VS OCF VS FCFGCTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

GCTK has a Return On Assets of -275.73%. This is amonst the worse of the industry: GCTK underperforms 95.72% of its industry peers.
With a Return On Equity value of -365.16%, GCTK is not doing good in the industry: 85.56% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -275.73%
ROE -365.16%
ROIC N/A
ROA(3y)-130.51%
ROA(5y)-147.55%
ROE(3y)-220.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GCTK Yearly ROA, ROE, ROICGCTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K -5K 10K 15K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for GCTK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GCTK Yearly Profit, Operating, Gross MarginsGCTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20K -40K -60K -80K

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for GCTK has been increased compared to 1 year ago.
Compared to 5 years ago, GCTK has more shares outstanding
GCTK has a better debt/assets ratio than last year.
GCTK Yearly Shares OutstandingGCTK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2K 4K 6K 8K 10K
GCTK Yearly Total Debt VS Total AssetsGCTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

GCTK has an Altman-Z score of 16.63. This indicates that GCTK is financially healthy and has little risk of bankruptcy at the moment.
GCTK has a better Altman-Z score (16.63) than 93.05% of its industry peers.
GCTK has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
GCTK has a Debt to Equity ratio of 0.03. This is in the better half of the industry: GCTK outperforms 65.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 16.63
ROIC/WACCN/A
WACCN/A
GCTK Yearly LT Debt VS Equity VS FCFGCTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

A Current Ratio of 4.85 indicates that GCTK has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.85, GCTK is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
GCTK has a Quick Ratio of 4.85. This indicates that GCTK is financially healthy and has no problem in meeting its short term obligations.
GCTK has a Quick ratio of 4.85. This is in the better half of the industry: GCTK outperforms 79.14% of its industry peers.
Industry RankSector Rank
Current Ratio 4.85
Quick Ratio 4.85
GCTK Yearly Current Assets VS Current LiabilitesGCTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for GCTK have decreased strongly by -46.56% in the last year.
EPS 1Y (TTM)-46.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GCTK Yearly Revenue VS EstimatesGCTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 200K 400K 600K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GCTK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GCTK Price Earnings VS Forward Price EarningsGCTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GCTK Per share dataGCTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1K -2K -3K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GCTK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GLUCOTRACK INC

NASDAQ:GCTK (7/2/2025, 3:41:53 PM)

6.5591

+0.25 (+3.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.69%
Inst Owner Change54.86%
Ins Owners0.87%
Ins Owner Change0.26%
Market Cap167.85M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 23.13
P/tB 23.13
EV/EBITDA N/A
EPS(TTM)-3287.38
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS0
BVpS0.28
TBVpS0.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -275.73%
ROE -365.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-130.51%
ROA(5y)-147.55%
ROE(3y)-220.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 135%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.85
Quick Ratio 4.85
Altman-Z 16.63
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5.42%
Cap/Depr(5y)35.05%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-72.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-205.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-204.49%
OCF growth 3YN/A
OCF growth 5YN/A